De nouveaux dirigeants et dirigeantes pour l'Institut canadien des actuaires à l'occasion de sa 60e année
Ottawa, Ontario--(Newsfile Corp. - 29 mai 2025) - Angelita Graham accède à la présidence de l'Institut canadien des actuaires (ICA) à compter du 1er juillet 2025.Graham, Fellow de l'ICA (FICA), apporte une riche expérience à ce poste par le fait d'avoir occupé plusieurs postes bénévoles et de direction au sein...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-29 12:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces the results from its Annual General Meeting of Shareholders (the "AGM") held...
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-05-29 7:27 AM EDT | Cardiol Therapeutics Inc.
Lyra Growth Partners Inc. Announces Sale of Common Shares of BuildDirect.com Technologies Inc.
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Lyra Growth Partners Inc. ("Lyra") announces that, on May 28, 2025, Lyra completed the private sale of an aggregate of 1,798,000 common shares (the "Common Shares") of BuildDirect.com Technologies Inc. ("BuildDirect") to four purchaser parties who are senior members of BuildDirect's...
Food/Beverages, Household/Consumer/Cosmetics, Health
2025-05-28 7:09 PM EDT | Lyra Growth Partners Inc.
Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, a leading German CBD retailer,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-28 1:52 PM EDT | Neural Therapeutics Inc.
Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name to Unbuzzd Wellness Inc.
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Unbuzzd Wellness Inc. (formerly, Celly Nutrition Corp.) (the "Company"), the company behind unbuzzdTM, the scientifically-proven beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, is pleased to announce that it has hired leading audit firm MNP LLP ("MNP") effective...
2025-05-28 8:00 AM EDT | Unbuzzd Wellness Inc.
Defence Therapeutics to Attend Bio International Convention in Boston, June 2025
Montreal, Quebec--(Newsfile Corp. - May 28, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced cancer therapeutics and drug delivery technologies, is pleased to announce that its Chief Executive Officer and Chief Operating Officer will be attending the...
Biotechnology, Pharmaceuticals, Health
2025-05-28 3:15 AM EDT | Defence Therapeutics Inc.
Rapid Dose Announces Proposed Equity Private Placement Financing
Burlington, Ontario--(Newsfile Corp. - May 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing (the "Financing") for up to $3,000,000 of gross proceeds, consisting of up to 13,636,364 units (the "Units") at a...
2025-05-27 5:03 PM EDT | Rapid Dose Therapeutics Corp.
Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc
Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), is pleased to announce, further to its press releases dated February 27, 2025, April 11, 2025 and April 23, 2025, that Solvonis Therapeutics plc (LSE: SVNS) ("Solvonis")...
Technology, Biotechnology, Health
2025-05-27 12:05 PM EDT | Awakn Life Sciences Corp.
Sona Successfully Completes FDA-Required Toxicity Study
Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety study evaluating for toxicity issues when animals are injected with its proprietary gold nanorods, conducted by CBSET, Inc. Donald Hodges,...
2025-05-27 8:27 AM EDT | Sona Nanotech Inc.
Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial
New York, New York--(Newsfile Corp. - May 27, 2025) - Psyence BioMed (NASDAQ: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company developing nature-derived psilocybin therapies for unmet mental health needs, today announced the finalization of its service agreement with Southern Star Research Pty Ltd ("Southern Star Research"), an award-winning,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-27 7:30 AM EDT | Psyence Biomedical Ltd.
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT
Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces that the Company's virtual Annual General Meeting of Shareholders (the "AGM") will...
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-05-27 7:27 AM EDT | Cardiol Therapeutics Inc.
Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology
Burlington, Ontario--(Newsfile Corp. - May 26, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar Oral Strips Pvt. Ltd. These...
2025-05-26 6:09 PM EDT | Rapid Dose Therapeutics Corp.
James Anderson Provides Update on Holdings of MyndTec Inc.
Detroit, Michigan--(Newsfile Corp. - May 26, 2025) - James Anderson (the "Investor") announces update to his ownership of common shares in the capital of MyndTec Inc. (the "Issuer") (the "Common Shares") and common share purchase warrants of the Issuer (the "Warrants").On May 22, 2025, the Issuer completed the second tranche...
Technology, Healthcare and Hospitals, Health
2025-05-26 4:15 PM EDT | James Anderson
PreveCeutical Welcomes Stephen Glover as Corporate Advisor
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that Steve Glover has been appointed as...
Biotechnology, Pharmaceuticals, Health
2025-05-26 7:00 AM EDT | PreveCeutical Medical Inc.
MyndTec Inc. Completes Second Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - May 23, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the second tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The second...
Technology, Healthcare and Hospitals, Health
2025-05-23 4:15 PM EDT | MyndTec Inc.
PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, following its news releases dated April 2, 2025, April 14, 2025, and April 28, 2025, it has successfully closed the final tranche ("Final Tranche") of...
Biotechnology, Pharmaceuticals, Health
2025-05-22 2:25 PM EDT | PreveCeutical Medical Inc.
Announcing the 2025 St. Baldrick's Summer Fellows: Investing in the Future of Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - May 22, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, is proud to announce the 2025 recipients of its Summer Fellow Awards. A total of $100,000 has been awarded to undergraduate and medical students to support hands-on research...
2025-05-22 12:07 PM EDT | St. Baldrick's Foundation
CORRECTION FROM SOURCE: Mobile-health Network Solutions Signs MOU to Add AI-enabled Dental Scans and Oral Health Screening to its Telemedicine Platform
This release corrects and replaces the press release issued by Mobile-health Network Solutions on May 20, 2025 at 8:30 AM EDT. The error occurred in the body where it should have read, "MNDR" instead of "MaNaDr”. The corrected press release follows in full below:Singapore, Singapore--(Newsfile Corp. - May 22, 2025) - Mobile-health Network...
2025-05-22 10:09 AM EDT | Mobile-health Network Solutions
Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval from the UAE DOH to commence Phase 2 clinical study (SKNJCT-004) to non-invasively treat BCC of the skin. The study is...
Banking/Financial Services, Biotechnology, Investment Banking, Health
2025-05-22 7:30 AM EDT | Medicus Pharma Ltd.
Delivra Health Brands Engages Global One Media and Bergskogar for Investor Relations Services
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that it has engaged Global One Media Group Pte. Ltd. ("Global...
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-05-22 7:20 AM EDT | Delivra Health Brands Inc.